Visionary Wealth Advisors Aurinia Pharmaceuticals Inc. Transaction History

Visionary Wealth Advisors

  • $1.57 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$5.94 - $11.27 $11,880 - $22,540
2,000 Added 18.69%
12,700 $139,000
Q3 2022

Nov 14, 2022
SELL
$6.66 - $12.39 $6,660 - $12,390
-1,000 Reduced 8.55%
10,700 $80,000
Q2 2022

Aug 12, 2022
BUY
$8.95 - $12.8 $8,950 - $12,800
1,000 Added 9.35%
11,700 $118,000
Q1 2022

May 12, 2022
BUY
$10.05 - $22.48 $107,535 - $240,536
10,700 New
10,700 $132,000

Others Institutions Holding AUPH

# of Institutions
208
Shares Held
58.1M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.14B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Visionary Wealth Advisors Portfolio

Follow Visionary Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Visionary Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Visionary Wealth Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email